These data indicated that the NEAT1/miR-590-3p/MDM2 axis played vital roles in the angiogenesis of ESCC and our results provided potential target for anti-cancer therapy in ESCC. This evidence concerns the gene MDM2 and esophageal squamous cell carcinoma.